Dataset Information


Human liver chimeric mouse model based on diphtheria toxin-induced liver injury.

ABSTRACT: To establish an inducible liver injury mouse model and transplant human hepatocytes to obtain liver-humanized mice.We crossed three mouse strains, including albumin (Alb)-cre transgenic mice, inducible diphtheria toxin receptor (DTR) transgenic mice and severe combined immune deficient (SCID)-beige mice, to create Alb-cre/DTR/SCID-beige (ADSB) mice, which coincidentally harbor Alb-cre and DTR transgenes and are immunodeficient. As the Cre expression is driven by the liver-specific promoter Alb (encoding ALB), the DTR stop signal flanked by two loxP sites can be deleted in the ADSB mice, resulting in DTR expression in the liver. ADSB mice aged 8-10 wk were injected intraperitoneally (i.p.) with diphtheria toxin (DT) and liver damage was assessed by serum alanine aminotransferase (ALT) level. Two days later, mouse livers were sampled for histological analysis, and human hepatocytes were transplanted into the livers on the same day. A human ALB enzyme-linked immunosorbent assay was performed 7, 14, 21 and 28 d after transplantation. Human CD68 immunohistochemistry was performed 30 and 90 d after transplantation.We crossed Alb-cre with DTR and SCID-beige mice to obtain ADSB mice. These mice were found to have liver damage 4 d after i.p. injection of 2.5 ng/g bodyweight DT. Bodyweight began to decrease on day 2, increased on day 7, and was lowest on day 4 (range, 10.5%-13.4%). Serum ALT activity began to increase on day 2 and reached a peak value of 289.7 ± 16.2 IU/mL on day 4, then returned to background values on day 7. After transplantation of human liver cells, peripheral blood human ALB level was 1580 ± 454.8 ng/mL (range, 750.2-3064.9 ng/mL) after 28 d and Kupffer cells were present in the liver at 30 d in ADSB mice.Human hepatocytes were successfully repopulated in the livers of ADSB mice. The inducible mouse model of humanized liver in ADSB mice may have functional applications, such as hepatocyte transplantation, hepatic regeneration and drug metabolism.


PROVIDER: S-EPMC5526763 | BioStudies | 2017-01-01

SECONDARY ACCESSION(S): 10.3748/wjg.v23.i27.4935

REPOSITORIES: biostudies

Similar Datasets

2015-01-01 | S-EPMC4414454 | BioStudies
1000-01-01 | S-EPMC4000440 | BioStudies
2019-01-01 | S-EPMC6606737 | BioStudies
2012-01-01 | S-EPMC3397120 | BioStudies
2015-01-01 | S-EPMC4633119 | BioStudies
2011-01-01 | S-EPMC2965206 | BioStudies
2018-01-01 | S-EPMC6279583 | BioStudies
2011-01-01 | S-EPMC3145049 | BioStudies
2011-01-01 | S-EPMC3103747 | BioStudies
2010-01-01 | S-EPMC2940888 | BioStudies